Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jay Badell

Podiatrist, Foot & Ankle Surgery Greenfield, IN Doctor of Podiatric Medicine

NPI 1679035034 CMS profile 7231636

801 N State St Ste 2100, Greenfield, IN 46140

Open in the dashboard

General payments

$44,833

105 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jay Badell of Greenfield, IN is reported in the CMS Open Payments database as having received $44,833 across 105 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $28,223 29
2024 General $7,315 25
2023 General $3,420 28
2022 General $3,067 13
2021 General $2,625 7
2020 General $153 2
2019 General $29 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jay Badell
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Jay Badell were reported at $28,223. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Jay Badell Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $29 $389 $118–$1,406 $163
2020 $153 $191 $62–$691 $114
2021 $2,625 $329 $104–$1,341 $132
2022 $3,067 $419 $125–$1,611 $149
2023 $3,420 $377 $128–$1,164 $160
2024 $7,315 $394 $134–$1,168 $164
2025 $28,223 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Linvatec Corporation $18,457 22 payments
  2. Alafair Biosciences,Inc. $13,615 10 payments
  3. Crossroads Orthopedics, LLC $3,629 5 payments
  4. Flower Orthopedics Coporation $2,017 4 payments
  5. Vilex in Tennessee, Inc. $1,983 11 payments
  6. Arthrex, Inc. $1,427 5 payments
  7. Extremity Medical $680 3 payments
  8. Smith+Nephew, Inc. $634 11 payments
  9. Stryker Corporation $412 5 payments
  10. Triad Life Sciences Inc. $232 2 payments
  11. Other $1,746 27 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $15,450 8 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,350 6 payments
  3. Travel and Lodging $5,779 15 payments
  4. Food and Beverage $5,454 72 payments
  5. Education $4,800 4 payments
Products named General payments · program years 2019–2025
  1. BIOBRACE 23MM $18,080 19 payments
  2. VersaWrap $13,615 10 payments
  3. HERCULES SUTURE ANCHOR SYSTEM In2bones $9,184 5 payments
  4. HERCULES SUTURE ANCHOR SYSTEM In2bones $2,500 1 payment
  5. HINTERMANN $1,983 11 payments
  6. Omni Mini $500 1 payment
  7. INBONE $317 3 payments
  8. STRAVIX $313 4 payments
  9. GRAFIX PL $254 5 payments
  10. INNOVAMATRIX AC $232 2 payments
  11. Other $4,188 52 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

116

Median for Podiatry: 160

Drug cost

$1,007

Median for Podiatry: $2,368

Branded share of claims

33.6%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 39 $380
Ondansetron Hcl Generic 27 $262
Ciprofloxacin Hcl Generic 15 $184
Cephalexin Generic 12 $122
Meloxicam Generic 12 $32
Tramadol Hcl Generic 11 $27

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$49,845

Medicare's payments for the services billed

Medicare patients

98

Average age 75

Services billed

578

55 women, 43 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 73%
Ischemic heart disease 39%
Diabetes 37%
Chronic kidney disease 33%
Depression 30%
Heart failure 19%
Cancer 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

105 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record